The Antiviral Lectin Q-GRFT is Safe and Effective in a Murine Model of HSV-2 Transmission

被引：0
|
作者：
Lasnik, Amanda [1 ]
Wang, Lin [2 ]
Rohan, Lisa [3 ]
Palmer, Kenneth [4 ]
机构：
[1] Univ Louisville, Brown Canc Ctr, Louisville, KY 40292 USA
[2] Magee Womens Res Inst & Fdn, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA
[4] Univ Louisville, Sch Med, Owensboro Canc Res Program, Louisville, KY 40292 USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2016年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P19.53LB
引用
收藏
页码：348 / 348
页数：1
相关论文
共 10 条
  • [1] Murine Model of Recurrent Vaginal HSV-2 Shedding and Effect of Acyclovir
    Cardin, Rhonda
    Farley, Nicholas
    Bravo, Fernando
    Earwood, Julie
    Sawtell, Nancy
    Bernstein, David
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A69 - A69
  • [2] Effect of the Potent Antiviral 1-Cinnamoyl-3,11-Dihydroxymeliacarpin on Cytokine Production by Murine Macrophages Stimulated with HSV-2
    Petrera, Erina
    Coto, Celia E.
    PHYTOTHERAPY RESEARCH, 2014, 28 (01) : 104 - 109
  • [3] The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
    Du, Qiuling
    Gu, Zhen
    Leneva, Irina
    Jiang, Haiming
    Li, Runfeng
    Deng, Liehua
    Yang, Zifeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 68 : 58 - 67
  • [4] Evaluation of the antiviral potential of the soluble forms of glycoprotein D receptors on ocular herpes caused by HSV-1 and HSV-2 infections in a transgenic mouse model
    Fujimoto, Yoshikazu
    Hikita, Shin-ichi
    Takeda, Keiko
    Ozaki, Kinuyo
    Inoue, Hideya
    Takakuwa, Hiroki
    Sonoda, Koh-hei
    Ono, Etsuro
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (05) : 820 - 828
  • [5] The type I interferon receptor is not required for protection in the Chlamydia muridarum and HSV-2 murine super-infection model
    Slade, Jessica A.
    Hall, Jennifer V.
    Kintner, Jennifer
    Schoborg, Robert V.
    PATHOGENS AND DISEASE, 2018, 76 (08):
  • [6] A Vaxfectin®-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes
    Veselenak, Ronald L.
    Shlapobersky, Mark
    Pyles, Richard B.
    Wei, Qun
    Sullivan, Sean M.
    Bourne, Nigel
    VACCINE, 2012, 30 (49) : 7046 - 7051
  • [7] Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes
    Bernstein, David, I
    Cardin, Rhonda D.
    Bravo, Fernando J.
    Hamouda, Tarek
    Pullum, Derek A.
    Cohen, Gary
    Bitko, Vira
    Fattom, Ali
    VACCINE, 2019, 37 (43) : 6470 - 6477
  • [8] Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
    Felker, Allison M.
    Nguyen, Philip
    Kaushic, Charu
    VIRUSES-BASEL, 2021, 13 (10):
  • [9] Engineering a safe monoclonal anti-human IL-2 that is effective in a murine model of food allergy and asthma
    Klein, Martin
    Misme-Aucouturier, Barbara
    Cheminant, Marie-Aude
    De Carvalho, Marion
    Wauters, Marie
    Tranquet, Olivier
    Magnan, Antoine
    Bouchaud, Gregory
    ALLERGY, 2022, 77 (03) : 933 - 945
  • [10] Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus
    Diaz, Fernando M.
    Knipe, David M.
    VIROLOGY, 2016, 488 : 61 - 67
1